Pharmetique Labs Venezuela
Pharmetique Labs Venezuela (Laboratorios La Santé, C.A.) is a 67-year-old Venezuelan pharmaceutical manufacturer operating four business units — Primary Care, OTC, Specialty Care (oncology), and Genéricos La Santé — distributing prescription, over-the-counter, and generic medicines through national pharmacies and physician channels.
- Company typePrivate
- Founded1956
- HeadquartersCaracas, Venezuela
- Headcount51–100
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Pharmetique Labs Venezuela does
Pharmetique Labs Venezuela, legally Laboratorios La Santé, C.A. (Tax ID J-00015493-7), is a privately held Venezuelan pharmaceutical manufacturer and commercializer founded in 1956 and operating for more than 67 years. The company is headquartered in Caracas (Cuarta transversal de Boleíta Sur, Edif. Centro Industrial Boleíta) with a manufacturing facility in Carabobo state (Condominio Industrial El Nepe), and employs approximately 71 people. It is registered under the trademark "La Santé" and currently trades under the corporate brand Pharmetique Labs. Distribution is exclusively domestic, with products available in pharmacies and national chains across Venezuela; there is no disclosed international footprint.
The company's product and commercial platform is organized into four business units: Primary Care (prescription products based on novel molecules and exclusive combinations recognized by physicians and pharmacists), OTC/Consumer (over-the-counter medications in allergo-respiratory, central nervous system, digestive-metabolic, musculoskeletal, and dermatological therapeutic areas, plus immune-support products such as vitamin C and probiotics), Specialty Care (oncology products for chronic and complex diseases), and Genéricos La Santé (prescription and OTC generics). Core activity spans pharmaceutical R&D, manufacturing, and commercialization. The go-to-market motion is sales-led and multi-channel: medical detailing (visita médica), pharmacy sales-floor presence (piso de ventas), pharmacy promotional activities (actividades de impulso), mass media, and educational content marketing aimed at disease prevention and wellness.
The revenue model is based on one-time sales of pharmaceutical products through retail pharmacies and physician-driven prescription channels. There is no public disclosure of pricing, no subscription or recurring component, and no externally disclosed revenue figure. The company reports no parent organization, no private equity or venture capital backing, no funding rounds, and no subsidiaries. It holds a Great Place to Work certification at regional credibility weight and markets itself as a multinational pharmaceutical science entity, although its operating geography is limited to Venezuela.
Pharmetique Labs Venezuela firmographics
Firmographics- Name
- Pharmetique Labs Venezuela
- Legal name
- Laboratorios La Santé, C.A.
- Website
- https://lasante.com.ve
- Company type
- Private
- Founded year
- 1956
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Pharmetique Labs Venezuela (Laboratorios La Santé, C.A.) is a 67-year-old Venezuelan pharmaceutical manufacturer operating four business units — Primary Care, OTC, Specialty Care (oncology), and Genéricos La Santé — distributing prescription, over-the-counter, and generic medicines through national pharmacies and physician channels.
- Ownership category
- akta.pro rank
Pharmetique Labs Venezuela industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
- akta.pro secondary industries
- Specialty Care Pharmaceuticals (HLAIAAAB), Generic Hospital & Institutional Products (HLAIABAL)
Keywords
Where Pharmetique Labs Venezuela is headquartered
LocationHeadquarters
- HQ city
- Caracas
- HQ country
- Venezuela
- HQ region
- Latin America
Offices2 records
Markets served
Pharmetique Labs Venezuela business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Products: Revenue generated from the manufacturing and commercialization of prescription generic drugs, over-the-counter medications, primary care products, and specialty oncology medications across Venezuela.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Pharmetique Labs Venezuela product offering
Product offeringCore offering
Pharmetique Labs Venezuela researches, develops, manufactures, and commercializes pharmaceutical products across four business units: prescription medications with novel molecules (Primary Care), over-the-counter self-care products (OTC), oncology specialty medications (Specialty Care), and generic prescription and OTC drugs (Genéricos La Santé). Products span therapeutic areas including allergo-respiratory, central nervous system, digestive-metabolic, musculoskeletal, dermatological, and immune support, and are distributed through pharmacies and healthcare channels across Venezuela.
Product overview
Pharmetique Labs is a pharmaceutical company operating as a multi-unit portfolio with four distinct business units: Primary Care (prescription medications with novel molecules), OTC (over-the-counter self-care products), Specialty Care (oncology products), and Generics La Santé (generic medications). The company has over 67 years of experience dedicated to the research, development, and commercialization of health products in Venezuela, offering products across therapeutic areas including allergo-respiratory, central nervous system, digestive/metabolic, musculoskeletal, and dermatological conditions, as well as immune support products like vitamin C and probiotics.
Differentiator
Problem solved
Functional benefit
Brands
- La Santé: Generic prescription and over-the-counter medications under the Genericos La Santé business unit.
- Primary Care
- Specialty Care
- OTC / Consumer
Products and services
- Primary Care Pharmaceutical business unit that produces and commercializes prescription medications based on novel molecules and exclusive combinations with strong brand recognition among doctors and pharmacists in Venezuela, covering a cutting-edge portfolio contributing to patient wellness and professional success.
- OTC (Over-the-Counter) Consumer Health Over-the-counter medications sold without medical prescription, distributed through all pharmacies and national chains in Venezuela. The portfolio includes products for immune system support (vitamin C, probiotics) and treatments for allergo-respiratory, central nervous system, digestive-metabolic, musculoskeletal, and dermatological therapeutic areas, targeting consumers seeking responsible self-care.
- Specialty Care Oncology Pharmaceutical business unit dedicated to research and commercialization of high-quality oncological products. Offers an extensive portfolio of oncology products emphasizing scientific innovation and pharmaceutical quality, used to treat complex or chronic diseases that require dedicated follow-up and careful administration.
- Genéricos La Santé Generic pharmaceutical business unit producing and commercializing prescription and over-the-counter generic products under the La Santé brand in Venezuela. Offers generic medications with proven effectiveness positioned as safe and effective alternatives to brand-name drugs, distributed through pharmacies and healthcare channels nationwide.
Companies that use Pharmetique Labs Venezuela
Customer profileSegments4 records
Ideal customer profiles4 records
Pharmetique Labs Venezuela technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Pharmetique Labs Venezuela partnerships and signals
Strategic signalScale indicators4 records
Recent moves4 records
Expansion highlights3 records
Pharmetique Labs Venezuela competitors and assessment
Company assessmentDirect peers
- Calox International: Venezuelan pharmaceutical manufacturer with generic and OTC portfolios. Competes head-to-head in the domestic pharmacy channel with overlapping therapeutic areas.
- Genomma Lab: Latin American OTC and personal care pharmaceutical company. Directly comparable to Pharmetique's OTC/Consumer business unit in self-care products marketed through mass-market pharmacy and media channels.
- Genfar: Latin American generics-focused pharmaceutical manufacturer (now part of Sanofi). Directly comparable to Pharmetique's Genericos La Santé unit in offering affordable generic prescription and OTC medications across the region.
- Leti (Grupo Leti): Venezuelan pharmaceutical group with branded generics, OTC, and specialty lines. Operates similar multi-segment business model targeting the same physician, pharmacist, and consumer channels in Venezuela.
- Laboratorios Klinos: Venezuelan pharmaceutical manufacturer producing branded generics and specialty products. Comparable domestic competitor with overlapping therapeutic categories and similar pharmacy-channel distribution in Venezuela.
Regional players
- Eurofarma: Major Brazilian pharmaceutical manufacturer with branded generics, specialty, and OTC portfolios across Latin America. Regional comparable with similar multi-segment model but operates primarily outside Venezuela.
Broad incumbents
- Bayer (Consumer Health and Pharma, Venezuela): Global pharmaceutical and consumer health major with established presence in Venezuela. Overlaps with Pharmetique across OTC self-care, primary care, and specialty therapeutic categories, but as part of a much broader global portfolio.
- Sanofi Venezuela: Global pharmaceutical major and owner of Genfar; competes across branded, specialty, and consumer health categories in Venezuela. Directly overlaps with multiple Pharmetique business units through local subsidiaries.
- Roche Venezuela: Global pharmaceutical leader with particularly strong oncology franchise. Directly comparable to Pharmetique's Specialty Care oncology unit in serving Venezuelan oncology prescribers and patients.
- Pfizer Venezuela: Global pharmaceutical major with primary care and specialty (including oncology) presence in Venezuela. Comparable in therapeutic breadth and medical-channel distribution but operates at much larger scale across a global portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Pharmetique Labs Venezuela social profiles
Digital presencePharmetique Labs Venezuela financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pharmetique Labs Venezuela leadership team
Management profileNumber of profiles
Pharmetique Labs Venezuela funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pharmetique Labs Venezuela M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pharmetique Labs Venezuela
What does Pharmetique Labs Venezuela do?
Pharmetique Labs Venezuela researches, develops, manufactures, and commercializes pharmaceutical products across four business units: prescription medications with novel molecules (Primary Care), over-the-counter self-care products (OTC), oncology specialty medications (Specialty Care), and generic prescription and OTC drugs (Genéricos La Santé). Products span therapeutic areas including allergo-respiratory, central nervous system, digestive-metabolic, musculoskeletal, dermatological, and immune support, and are distributed through pharmacies and healthcare channels across Venezuela.
Is Pharmetique Labs Venezuela a public or private company?
Pharmetique Labs Venezuela is a private company. It is classified as family owned and is currently operating.
When was Pharmetique Labs Venezuela founded?
Pharmetique Labs Venezuela was founded in 1956. It employs 51 to 100 people.
Where is Pharmetique Labs Venezuela based?
Pharmetique Labs Venezuela is headquartered in Caracas, Venezuela, in the Latin America region.
How does Pharmetique Labs Venezuela make money?
One revenue line is on record: pharmaceutical Products.
Who are Pharmetique Labs Venezuela's main competitors?
Direct peers on record are Calox International, Genomma Lab, Genfar, Leti (Grupo Leti) and Laboratorios Klinos. Eurofarma is listed as a regional player. Broad incumbents are Bayer (Consumer Health and Pharma, Venezuela), Sanofi Venezuela, Roche Venezuela and Pfizer Venezuela.
Does Pharmetique Labs Venezuela have an API?
No public API is recorded for Pharmetique Labs Venezuela.
What industry is Pharmetique Labs Venezuela in?
Pharmetique Labs Venezuela's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.